JAZZ
Jazz Pharmaceuticals plc
Company Overview
| Mkt Cap | $8.38B | Price | $137.64 |
| Volume | 524.52K | Change | +0.98% |
| P/E Ratio | 15.0 | Open | $136.78 |
| Revenue | $4.1B | Prev Close | $136.30 |
| Net Income | $560.1M | 52W Range | $95.49 - $148.06 |
| Div Yield | N/A | Target | $187.81 |
| Overall | 60 | Value | 40 |
| Quality | -- | Technical | 80 |
No chart data available
Stock Overview
Updated DailyJazz Pharmaceuticals plc (JAZZ) is a leading Healthcare company in the Biotechnology industry, currently trading at $137.64 with a market capitalization of $8.38 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows JAZZ with a volume of 525K shares. The stock opened up 0.35% from yesterday's close of $136.30. Current analyst estimates project earnings of $1.76 per share for this year, with next year targeting $18.85.
JAZZ demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including ENDP, ABC, TEVA, NVS.
Key investment considerations for JAZZ include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 36.5%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 2, 2025 at 09:44 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | JAZZ | $137.64 | +1.0% | 524.52K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Jazz Pharmaceuticals plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW